BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23365120)

  • 1. Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency.
    Reisch N; Idkowiak J; Hughes BA; Ivison HE; Abdul-Rahman OA; Hendon LG; Olney AH; Nielsen S; Harrison R; Blair EM; Dhir V; Krone N; Shackleton CH; Arlt W
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E528-36. PubMed ID: 23365120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype.
    Shackleton C; Marcos J; Arlt W; Hauffa BP
    Am J Med Genet A; 2004 Aug; 129A(2):105-12. PubMed ID: 15316970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Zhang J; Woo KL; Hai Y; Wang S; Lin Y; Huang Y; Peng X; Wu H; Zhang S; Yan L; Li Y
    Front Endocrinol (Lausanne); 2022; 13():1020880. PubMed ID: 36518257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined homozygous 21 hydroxylase with heterozygous P450 oxidoreductase mutation in a Saudi boy presented with hypertension.
    Aljabri A; Alnaim F; Alsaleh Y
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32994263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Krone N; Reisch N; Idkowiak J; Dhir V; Ivison HE; Hughes BA; Rose IT; O'Neil DM; Vijzelaar R; Smith MJ; MacDonald F; Cole TR; Adolphs N; Barton JS; Blair EM; Braddock SR; Collins F; Cragun DL; Dattani MT; Day R; Dougan S; Feist M; Gottschalk ME; Gregory JW; Haim M; Harrison R; Olney AH; Hauffa BP; Hindmarsh PC; Hopkin RJ; Jira PE; Kempers M; Kerstens MN; Khalifa MM; Köhler B; Maiter D; Nielsen S; O'Riordan SM; Roth CL; Shane KP; Silink M; Stikkelbroeck NM; Sweeney E; Szarras-Czapnik M; Waterson JR; Williamson L; Hartmann MF; Taylor NF; Wudy SA; Malunowicz EM; Shackleton CH; Arlt W
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E257-67. PubMed ID: 22162478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/ tetrahydroxycortisone ratio and 11β-hydroxyandrosterone.
    Koyama Y; Homma K; Fukami M; Miwa M; Ikeda K; Ogata T; Hasegawa T; Murata M
    Clin Chem; 2012 Apr; 58(4):741-7. PubMed ID: 22273564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic challenges and management advances in cytochrome P450 oxidoreductase deficiency, a rare form of congenital adrenal hyperplasia, with 46, XX karyotype.
    Wang C; Tian Q
    Front Endocrinol (Lausanne); 2023; 14():1226387. PubMed ID: 37635957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone.
    Homma K; Hasegawa T; Nagai T; Adachi M; Horikawa R; Fujiwara I; Tajima T; Takeda R; Fukami M; Ogata T
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2643-9. PubMed ID: 16608896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of congenital adrenal hyperplasia.
    Krone N; Arlt W
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):181-92. PubMed ID: 19500762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects.
    Fukami M; Ogata T
    Pediatr Int; 2014 Dec; 56(6):805-808. PubMed ID: 25294558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency.
    Hershkovitz E; Parvari R; Wudy SA; Hartmann MF; Gomes LG; Loewental N; Miller WL
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3584-8. PubMed ID: 18559916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal serum and urine steroid metabolite profiling in a 46,XY infant with prenatally identified POR deficiency.
    Ono H; Numakura C; Homma K; Hasegawa T; Tsutsumi S; Kato F; Fujisawa Y; Fukami M; Ogata T
    J Steroid Biochem Mol Biol; 2018 Apr; 178():177-184. PubMed ID: 29289577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency: a case series.
    Sun M; Mueller JW; Gilligan LC; Taylor AE; Shaheen F; Noczyńska A; T'Sjoen G; Denvir L; Shenoy S; Fulton P; Cheetham TD; Gleeson H; Rahman M; Krone NP; Taylor NF; Shackleton CHL; Arlt W; Idkowiak J
    Eur J Endocrinol; 2021 Oct; 185(5):729-741. PubMed ID: 34524979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency.
    Williamson L; Arlt W; Shackleton C; Kelley RI; Braddock SR
    Am J Med Genet A; 2006 Sep; 140A(17):1797-803. PubMed ID: 16906539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid sulphatase deficiency is the major cause of extremely low oestriol production at mid-pregnancy: a urinary steroid assay for the discrimination of steroid sulphatase deficiency from other causes.
    Glass IA; Lam RC; Chang T; Roitman E; Shapiro LJ; Shackleton CH
    Prenat Diagn; 1998 Aug; 18(8):789-800. PubMed ID: 9742566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-classic cytochrome P450 oxidoreductase deficiency strongly linked with menstrual cycle disorders and female infertility as primary manifestations.
    Papadakis GE; Dumont A; Bouligand J; Chasseloup F; Raggi A; Catteau-Jonard S; Boute-Benejean O; Pitteloud N; Young J; Dewailly D
    Hum Reprod; 2020 Apr; 35(4):939-949. PubMed ID: 32242900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
    Carlson AD; Obeid JS; Kanellopoulou N; Wilson RC; New MI
    J Steroid Biochem Mol Biol; 1999; 69(1-6):19-29. PubMed ID: 10418977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical features of p450 oxidoreductase deficiency.
    Scott RR; Miller WL
    Horm Res; 2008; 69(5):266-75. PubMed ID: 18259105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency.
    Scott RR; Gomes LG; Huang N; Van Vliet G; Miller WL
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2318-22. PubMed ID: 17389698
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.